A Phase 1 Study of MM-141 in Patients with Advanced Solid Tumors
Phase of Trial: Phase I
Latest Information Update: 02 Dec 2016
At a glance
- Drugs Istiratumab (Primary) ; Everolimus; Gemcitabine; Paclitaxel
- Indications Solid tumours
- Focus Adverse reactions; First in man
- Sponsors Merrimack Pharmaceuticals
- 02 Dec 2016 Results of this trial, presented at the 28th EORTC-NCI-AACR Symposium on Molecular Targets and Cancer Therapeutics.
- 02 Mar 2016 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 03 Jun 2015 Planned primary completion date changed from 1 Aug 2014 to 1 May 2016, according to ClinicalTrials.gov record.
Most Recent Events
Table of Contents
- At a glance
- Trial Overview
- Trial Details
- Trial Centres
- Trial History